Helius Medical Technologi... (HSDT)
0.45
-0.02 (-4.96%)
At close: Mar 03, 2025, 3:59 PM
0.45
0.00%
After-hours: Mar 03, 2025, 04:51 PM EST
Helius Medical Technologies Inc. Revenue Breakdown
Quarter | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Product Revenue | 183K | 251K | 102K | 63K | 77K | 184K | 124K | 126K | 191K | 159K | 150K | 469K |
Product Revenue Growth | -27.09% | +146.08% | +61.90% | -18.18% | -58.15% | +48.39% | -1.59% | -34.03% | +20.13% | +6.00% | -68.02% | n/a |
Revenue by Geography
Quarter | Dec 31, 2023 | Dec 31, 2022 |
---|---|---|
Canada Revenue | 281K | 460K |
Canada Revenue Growth | -38.91% | n/a |
United States Revenue | 324K | 318K |
United States Revenue Growth | +1.89% | n/a |
Operating Expense Breakdown
Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 2.85M | 2.46M | 2.63M | 1.63M | 2.2M | 2.57M | 2.87M | 1.97M | 3.39M | 2.46M | 2.82M | 2.38M | 2.86M | 4.74M | 2.2M | 2.09M | 2.37M | 2.39M | 2.86M | 3.81M | 4.29M | 3.85M | 4.58M | 3.58M | 2.58M | 8.89M | 2.17M | 2.6M | 2.17M | 1.69M | 2.01M | 405K | 2.04M | 1.45M | 1.93M | 1.55M | 818.33K | 1.45M | -5.24M |
Selling, General, and Administrative Revenue Growth | +16.00% | -6.68% | +61.34% | -25.68% | -14.52% | -10.61% | +46.11% | -42.03% | +37.87% | -12.70% | +18.64% | -16.89% | -39.73% | +115.93% | +5.17% | -11.86% | -1.00% | -16.35% | -24.80% | -11.30% | +11.60% | -16.07% | +27.89% | +38.78% | -70.95% | +310.44% | -16.86% | +19.89% | +28.83% | -16.31% | +397.46% | -80.17% | +40.86% | -25.01% | +24.82% | +89.29% | -43.50% | -127.66% | n/a |
Research and Development Revenue | 1.08M | 870K | 788K | 650K | 722K | 684K | 886K | 794K | 751K | 953K | 1.76M | 1.81M | 1.49M | 1.38M | 1.32M | 827K | 1.33M | 1.31M | 1.12M | 1.6M | 1.51M | 2.27M | 2.68M | 2.16M | 2.31M | 2.92M | 2.55M | 3.27M | 3.8M | 4.29M | 3.02M | 1.56M | 1.35M | 653.88K | 981.73K | 1.29M | 243.26K | 1.39M | 1.21M |
Research and Development Revenue Growth | +23.79% | +10.41% | +21.23% | -9.97% | +5.56% | -22.80% | +11.59% | +5.73% | -21.20% | -45.98% | -2.43% | +21.42% | +8.13% | +4.64% | +59.13% | -37.68% | +1.45% | +16.79% | -29.96% | +6.18% | -33.80% | -15.14% | +24.18% | -6.50% | -20.95% | +14.46% | -21.86% | -14.01% | -11.55% | +42.24% | +93.64% | +15.64% | +106.18% | -33.40% | -23.99% | +430.95% | -82.46% | +14.55% | n/a |